The therapeutic use of this drug in veterinary medicine can lead to the detection of residues in tissues of treated animals that will be destined for human consumption. For this reason, the health authorities have prohibited the use of these substances in animal feed and in all phases of production, processing and marketing.

The controls to ensure that this is met are mainly focused on the target tissues, which are those that can concentrate the greatest amounts, and a maximum residue limit (MRL) is established after the use of this medicine (expressed in µg/kg on a fresh weight basis), which is authorized by the European Union.